NVS NOVARTIS AG-SPONSORED ADR
2026Q1 · CUSIP 66987V109 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
1,576
Δ holders QoQ
+85
Breadth percentile
Top 2%
Whale holders
205
Δ whales
+3
Inst. holding value
$21.7B
New positions
200
Closed positions
115
Price momentum (1Q)
-7.5%
Put / Call
19/15
Breadth history (34 quarters)
Past Lit Events & Aftermath 16 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 2% | — | — |
| 2025Q4 | Top 3% | -7.5% | — |
| 2025Q2 | Top 10% | +5.8% | +33.4% |
| 2025Q1 | Top 18% | +12.9% | +18.8% |
| 2024Q4 | Top 14% | +7.7% | +21.6% |
| 2024Q2 | Top 3% | -9.9% | -6.8% |
| 2023Q4 | Top 8% | +6.2% | +20.1% |
| 2023Q3 | Top 8% | +9.2% | +13.5% |
Options Sentiment
Put holders
19
QoQ: +3
Call holders
15
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
21.1
EPS (TTM)
$7.15
EPS YoY
+21.8%
Revenue (TTM)
$54.5B
Revenue YoY
+8.4%
As of 2025-12-31 · SEC filings (XBRL)